INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 46h ago
House PTR6h ago
SEC 13F6h ago
Robinhood Chain6h ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Form 4 transactions

21,973 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
32
HJ
Hoitt JasonChief Patient Officer
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$986
30 sh
Mar 18, 2026Mar 19, 2026
Page 370 of 550
← PrevNext →
traded Mar 18, 2026
+1d
SEC Form 4

Evidence

32
HL
Hurley Joseph LChief Supply Chain Officer
SFMSprouts Farmers Market, Inc.
Open-market sale
SELL$38K
456 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

32
CK
Coffin KimSVP, Chief Forager
SFMSprouts Farmers Market, Inc.
Open-market sale
SELL$39K
467 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

32
ZT
Zalatoris TimmiChief Human Resources Officer
SFMSprouts Farmers Market, Inc.
Open-market sale
SELL$40K
480 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

32
HJ
Hoitt JasonChief Patient Officer
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$4,419
139 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

32
LT
Leggett ThomasChief Financial Officer
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$1,215
37 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

32
JF
Jones Stephen FrancisDirector
WLFCWILLIS LEASE FINANCE CORP
Open-market sale
SELL$98K
587 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

30
LD
Lam DennisDirector
HFFGHF Foods Group Inc.
Open-market purchase
BUY$176
100 sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

29
AN
Agrawal NitinChief Financial Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$711K
8,666 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

29
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$2,365
72 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

29
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$11K
334 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

28
WR
Wills Phillip R. IIIDirector
FVCBFVCBankcorp, Inc.
Open-market sale
SELL$170K
11.5K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

28
LA
Liegel Matthew AChief Accounting Officer
TGTTARGET CORP
Open-market sale
SELL$241K
2,053 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

28
VH
von Heynitz HaraldDirector
FLNCFluence Energy, Inc.
Open-market sale
SELL$165K
10.0K sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

28
RL
Reed Marcy L.Director
CLHCLEAN HARBORS INC
Open-market sale
SELL$241K
836 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

23
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Open-market sale · 10b5-1 plan
SELL$60K
5,000 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

23
CV
Capital V LLC10% Owner
DSPViant Technology Inc.
Open-market sale · 10b5-1 plan
SELL$100K
8,760 sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

23
AN
Agrawal NitinChief Financial Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$25K
300 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

23
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Open-market sale · 10b5-1 plan
SELL$60K
5,000 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

23
GA
Geller AdamChief Product Officer
ZSZscaler, Inc.
Open-market sale · 10b5-1 plan
SELL$233K
1,485 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

23
CV
Capital V LLC10% Owner
DSPViant Technology Inc.
Open-market sale · 10b5-1 plan
SELL$180K
15.0K sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

22
GA
Geller AdamChief Product Officer
ZSZscaler, Inc.
Open-market sale · 10b5-1 plan
SELL$321K
2,094 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

22
WM
Woolsey Staci MChief Financial Officer
GVAGRANITE CONSTRUCTION INC
Open-market sale · 10b5-1 plan
SELL$183K
1,523 sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

21
LT
Larkin Kyle TDirector, President & CEO
GVAGRANITE CONSTRUCTION INC
Open-market sale · 10b5-1 plan
SELL$877K
7,314 sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

21
TS
Tamari ShaharDirector, COO
GLBEGlobal-E Online Ltd.
Open-market sale · 10b5-1 plan
SELL$563K
16.7K sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

20
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$86K
2,587 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

20
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Open-market sale · 10b5-1 plan
SELL$33K
2,920 sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

20
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$117K
3,577 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

20
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$191K
6,100 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

20
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Open-market sale · 10b5-1 plan
SELL$33K
2,920 sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

20
BA
Beer James ADirector
ZSZscaler, Inc.
Open-market sale · 10b5-1 plan
SELL$27K
177 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

19
CV
Capital V LLC10% Owner
DSPViant Technology Inc.
Open-market sale · 10b5-1 plan
SELL$177K
15.0K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

19
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Open-market sale · 10b5-1 plan
SELL$59K
5,000 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

19
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Open-market sale · 10b5-1 plan
SELL$59K
5,000 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

18
KA
Kelly Patrick ArthurCo-President and COO
CIFRCipher Digital Inc.
Open-market sale · 10b5-1 plan
SELL$533K
35.6K sh
Mar 16, 2026Mar 19, 2026
traded Mar 16, 2026
+3dSEC Form 4

Evidence

16
BD
Baroni DarioPresident, IDL
MCDMCDONALDS CORP
Open-market sale · 10b5-1 plan
SELL$194K
600 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

15
PJ
Peterson JustinChief Technology Officer
TWTradeweb Markets Inc.
Open-market sale · 10b5-1 plan
SELL$401K
3,212 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

15
VO
Verjus Nathalie Claude OdileCompany Secretary
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$15K
5,000 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

13
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$15K
483 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

13
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$3,384
103 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K